InVitro Cell Research, LLC
Kirstie Stansfield is a highly experienced professional in the field of neuroscience and regenerative medicine. Kirstie currently holds the position of Chief Operating Officer at InVitro Cell Research, LLC, where Kirstie also serves as the Principal Scientist and Head of Neuroregeneration. Prior to that, Kirstie has held various roles at prestigious institutions such as Eli Lilly and Company, Columbia University Irving Medical Center, and Johns Hopkins University. With a strong educational background in neuroscience, including a PhD from the University of South Florida, Kirstie's expertise lies in research related to brain anti-aging, neuroprotection, and regenerative medicine using iPSC-derived cell models.
This person is not in the org chart
InVitro Cell Research, LLC
InVitro Cell Research, LLC (ICR) is a privately funded company focused on regenerative and preventive personalized medicine. We are dedicated to discovering and developing interventions to slow and reverse biological aging and prevent major age-related diseases. ICR has a small-group vibe and a highly collaborative work environment. We invest in our scientists, providing them the state-of-the-art resources they need to leverage their time and skills most effectively, empowering small teams to accomplish the amazing and advance our mission. Our mission is to research ways to repair aging people, fast.